4d pharma PLC (LSE:DDDD) - Share price


Stock Report

4d pharma PLC DDDD

Last Price
GBX95.00

Day Change
1.00|1.06%

As of 17/07/2019
08:46:15 BST | GBX
Minimum 15 Minutes Delay.

Last Close94.00p
Day Range95.35 - 95.35
Mkt Cap62.22Mil
52-Wk Range77.00 - 197.00
Yield %-
ISINGB00BJL5BR07
Volume10,474
P/E-2.63
P/S-
P/CF-0.03

Share Price

Total Returns 17/07/2019

 Chg (%)  
More ...
4d pharma PLC0.53 
FTSE 100 TR GBP2.56
 
Financials
201620172018
More ...
Income Statement
Turnover---
Operating Profit-13.09-20.36-29.12
Net Profit-9.86-20.45-23.69
Reported EPS-15.21-31.41-36.17
Balance Sheet
Current Assets74.9857.8033.16
Non Current Assets18.1819.9419.45
Total Assets93.1677.7452.61
Current Liabilities4.944.985.18
Total Liabilities---
Total Equity86.4869.7945.76
Cash Flow
Operating Cash Flow-13.53-17.19-22.94
Net Change in Cash26.88-16.804.19
Director Dealings
TradedActionNotifierPriceAmountValue
More ...
29/05/2019PurchaseDavid Robert Norwood100.0015,00015,000.00
22/05/2019PurchaseDuncan Joseph Peyton105.009,89110,386.00
21/05/2019PurchaseDr Alexander James Stevenson98.0050,99849,978.00
21/05/2019PurchaseDavid Robert Norwood96.005,0004,800.00

Company Profile

4d pharma PLC through its subsidiaries is involved in the business of research and development and manufacturing of live biotherapeutic products for the diseases such as cancer, asthma, autism, arthritis and multiple scelerosis.

Sector

Biotechnology

Index

FTSE AIM All-Share

Next Event 28/09/2019

Half-Yearly Results
Ratios
Comp
More ...
PER (E)0.00
Div Yld (E)0.00
PEG (E)0.00
ROCE-59.95
Op Mrgn0.00
EPS Grwth0.00
Dividends
PreviousLatest
More ...
Record Datet.b.c.t.b.c.
Ex-Divt.b.c.t.b.c.
Paidt.b.c.t.b.c.
Amnt0.000.00
Directors
More ...
Executive Director, Chief Scientific OfficerDr Alexander James Stevenson
Non-Executive Director, ChairmanDavid Robert Norwood
Executive Director, Chief Executive OfficerDuncan Joseph Peyton
Non-Executive DirectorMr. Thomas Engelen
AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2019 Morningstar. All rights reserved.